Cargando…

Value of ablation therapy in the treatment of lung metastases

Tumor metastases are the basic biological characteristics of malignant tumors, and the lungs are the second most prominent metastatic organs in which these develop after the liver. Currently, with the rapid development of ablation technology, ablation therapy as a local treatment is playing an incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Han, Fan, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792733/
https://www.ncbi.nlm.nih.gov/pubmed/29193688
http://dx.doi.org/10.1111/1759-7714.12567
_version_ 1783296798434000896
author Qi, Han
Fan, Weijun
author_facet Qi, Han
Fan, Weijun
author_sort Qi, Han
collection PubMed
description Tumor metastases are the basic biological characteristics of malignant tumors, and the lungs are the second most prominent metastatic organs in which these develop after the liver. Currently, with the rapid development of ablation technology, ablation therapy as a local treatment is playing an increasingly important role in the treatment of lung metastases. Whether alone or in combination with other treatments, ablation therapy has achieved good therapeutic effects for the treatment of partial lung metastases. This article briefly summarizes the results of current and previous ablation treatments for lung metastases, and focuses on the value of ablation therapy for different kinds of lung metastases.
format Online
Article
Text
id pubmed-5792733
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-57927332018-02-12 Value of ablation therapy in the treatment of lung metastases Qi, Han Fan, Weijun Thorac Cancer Invited Review Tumor metastases are the basic biological characteristics of malignant tumors, and the lungs are the second most prominent metastatic organs in which these develop after the liver. Currently, with the rapid development of ablation technology, ablation therapy as a local treatment is playing an increasingly important role in the treatment of lung metastases. Whether alone or in combination with other treatments, ablation therapy has achieved good therapeutic effects for the treatment of partial lung metastases. This article briefly summarizes the results of current and previous ablation treatments for lung metastases, and focuses on the value of ablation therapy for different kinds of lung metastases. John Wiley & Sons Australia, Ltd 2017-11-29 2018-02 /pmc/articles/PMC5792733/ /pubmed/29193688 http://dx.doi.org/10.1111/1759-7714.12567 Text en © 2017 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Invited Review
Qi, Han
Fan, Weijun
Value of ablation therapy in the treatment of lung metastases
title Value of ablation therapy in the treatment of lung metastases
title_full Value of ablation therapy in the treatment of lung metastases
title_fullStr Value of ablation therapy in the treatment of lung metastases
title_full_unstemmed Value of ablation therapy in the treatment of lung metastases
title_short Value of ablation therapy in the treatment of lung metastases
title_sort value of ablation therapy in the treatment of lung metastases
topic Invited Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792733/
https://www.ncbi.nlm.nih.gov/pubmed/29193688
http://dx.doi.org/10.1111/1759-7714.12567
work_keys_str_mv AT qihan valueofablationtherapyinthetreatmentoflungmetastases
AT fanweijun valueofablationtherapyinthetreatmentoflungmetastases